CHAPTER
He-W 900 OTHER PROGRAMS ADMINISTERED BY
THE DEPARTMENT OF HEALTH AND HUMAN SERVICES
PART He-W 910 – RESERVED
He-W 910.01
Source. #6925, eff 1-1-99; amd by #7666, eff 4-1-02;
ss by #8227, eff 1-1-05; rpld by #10139, eff 7-1-12
He-W 910.02
Source. #6925, eff 1-1-99; ss by #8227, eff 1-1-05; rpld by #10139, eff 7-1-12
He-W
910.03 & He-W 910.04
Source. #6925, eff 1-1-99; ss by #7804, eff 1-1-03;
ss by #8227, eff 1-1-05; rpld by #10139, eff 7-1-12
He-W
910.05
Source. #6925, eff 1-1-99; ss by #8227, eff 1-1-05; rpld by #10139, eff 7-1-12
He-W 910.06
Source. #6925, eff 1-1-99; ss by #8227, eff 1-1-05;
ss by #8467, eff 10-29-05; ss by #9513, INTERIM, eff 7-18-09, EXPIRES: 1-14-10;
ss by #9617, eff 1-14-10; rpld by #10139, eff 7-1-12
He-W
910.07
Source. #6925, eff 1-1-99; ss by #8227, eff 1-1-05;
ss by #8467, eff 10-29-05; ss by #9747, eff 7-1-10; rpld
by #10139, eff 7-1-12
He-W
910.08
Source. #6925, eff 1-1-99; ss by #8227, eff 1-1-05; rpld by #10139, eff 7-1-12
He-W
910.09
Source. #7666, eff 4-1-02; ss by #8227, eff 1-1-05; rpld by #10139, eff 7-1-12
He-W
910.10
Source. #8227, eff 1-1-05; rpld
by #10139, eff 7-1-12
PART He-W 950
COMPREHENSIVE HEALTH CARE INFORMATION SYSTEM PROCEDURES FOR THE RELEASE
OF CLAIMS DATA SETS FOR PUBLIC AND RESEARCH PURPOSES
He-W 950.01 Purpose. This part specifies the requirements,
procedures, and conditions under which persons other
than department personnel may have access to health care claims data sets.
Source. #8600, eff
4-6-06; ss by #10703, eff 10-23-14; ss by #14166, eff 1-7-25
He-W 950.02 Scope. This chapter shall apply only to data
collected under RSA 420-G:11, II.
Source. #8600, eff
4-6-06; ss by #10703, eff 10-23-14; ss by #14166, eff 1-7-25
He-W 950.03 Definitions.
(a) “Cell size” means the count of patients that
share a set of characteristics contained in a statistical table.
(b) “Commissioner” means the commissioner of the
New Hampshire department of health and human services or the commissioner’s
designee.
(c) “Confidential data” means individual or
collective data elements contained in the claims data set that:
(1)
Have not been revealed previously to the general
public; and
(2)
Directly identify a patient.
(d) “Department” means the
(e) “Direct patient identifiers” means:
(1)
Names;
(2)
Business names when that name would serve to identify a patient;
(3)
Postal address information other than town or city, state, and 5-digit
zip code;
(4)
Specific latitude and longitude or other geographic information that
would be used to derive postal address;
(5)
Telephone and fax numbers that identify a patient;
(6)
Electronic mail addresses that identify a patient;
(7)
Social security numbers that identify a patient;
(8)
Medical record numbers;
(9)
Health plan beneficiary numbers;
(10)
Certificate and license numbers that identify a patient;
(11)
Internet protocol addresses and uniform resource locators that identify
a business that would serve to identify a patient;
(12)
Biometric identifiers, including finger and voice prints; and
(13)
Personal photographic images.
(f) “Disclosure” means to communicate clinical or
other health care information data collected pursuant to RSA 420-G:11, II, to a
person not already in possession of that information.
(g) “Encrypted” means a method by which the true
value of data has been disguised in order to prevent
the identification of persons or groups and which does
not provide the means for recovering the true value of the data.
(h) “Health care claims data sets” means
information consisting of or derived directly from member eligibility files, or
medical, pharmacy, or dental claims files submitted by health care claims
processors collected under RSA 420-G:11, II, and include:
(1)
Public use data sets; and
(2)
Limited use data sets.
(i) “Health care practitioner” means physicians
and all persons licensed or registered as a health care provider in the state
of
(1) Nurses;
(2) Podiatrists;
(3) Optometrists;
(4) Pharmacists;
(5) Chiropractors;
(6) Physical therapists;
(7) Dentists;
(8) Psychologists;
(9) Licensed clinical social workers;
(10) Marriage and family therapists;
(11) Professional counselors; and
(12) Physicians’ assistants.
(j) “Indirect patient
identifier” means:
(1)
All geographic subdivisions of New Hampshire or any state or province,
including census tracts, blocks, and block groups, cities, towns, zip codes,
and their equivalent geocodes, except county;
(2)
Race and ethnicity;
(3)
All elements of dates, except year, for dates related to a patient,
including birth date, admission date, discharge date, date of death, and all
ages over 89 and all elements of dates, including year, indicative of such age,
except that such elements may be aggregated into a single category of age 90
and older; and
(4)
Group policy numbers.
(k)
“Limited use data set” means a health care claims data set that contains
restricted data elements, which might be disclosed to an outside party for
research purposes without the patient’s authorization when:
(1)
All direct patient identifiers have been encrypted in such a way as to
not allow direct identification, and to prevent linkage to other data sets
where the patient can be directly identified;
(2)
Any data that directly identifies or would lead to the indirect
identification of health care practitioners performing abortions has been
removed; and
(3)
All insured group or policy numbers cannot be
used to directly identify a patient.
(l) “Patient” means any person in the data set
that is the subject of the activities of the claim performed by the health care
provider.
(m) “Principal investigator” means the person in
charge of a project that makes use of limited use data sets, and acts as the custodian of the data who is responsible
for the observance of all conditions of use and for establishment and
maintenance of security arrangements to prevent unauthorized use.
(n) “Public use data set” means a data set that
is publicly available, contains data collected under RSA 420-G:11, II, is free
of confidential data, and from which all known direct or indirect patient
identifiers have been removed in accordance with 45 CFR 164.514(a)-(b).
(o) “Release” means to make all or part of the
claims data set available for inspection and analysis to persons other than the
department and the
(p) “Research” means “research” as defined in 45
CFR 46.102(l).
(q) “Statistical table” means single or
multivariate counts based on the information contained in a data set and which
does not include any direct identifiers.
Source. #8600, eff
4-6-06; ss by #10703, eff 10-23-14; ss by #14166, eff 1-7-25
He-W 950.04 Release of Public Use Data Sets.
(a) Public use data sets collected or generated
by the department or its designee shall be made
available in public use files and provided to any person upon written request,
except where otherwise prohibited by law.
(b) A person may request public use data sets by
completing and submitting a “Request Form for NH Commercial Claims Public Use
Data Set” (December 2024).
Source. #8600, eff
4-6-06; ss by #10703, eff 10-23-14 (from He-W 950.05); ss
by #14166, eff 1-7-25
He-W
950.05 Release of Limited Use Data
Sets.
(a) In
accordance with 45 CFR 164.514(e)(3)(i), limited use
data sets shall only be released for purposes of research.
(b) Any researcher requesting access to limited
use data sets shall submit:
(1) A completed “Application for
Access to New Hampshire Limited Use Commercial Health Claims Research Data
Sets” form (December 2024) and shall execute a contract which describes the
permitted uses of data;
(2) A copy of existing research protocols, if
applicable; and
(3) Approval from an institutional review board,
if applicable.
(c)
Except as otherwise provided by law, the department shall release the
requested limited data sets when:
(1) The application is complete pursuant to (b)
above;
(2) The applicant demonstrates the following:
a.
How inventory of data files will be maintained and updated;
b.
That physical access to the data files will be restricted to only
research staff;
c.
That safeguards are in place for research staff, having access to the
data files, including but not limited to confidentiality agreements and
training on stewardship responsibilities;
d.
Procedures for tracking active employment and project participation
status of research staff throughout the life the
project(s);
e.
The technical and physical safeguards which will be performed to
maintain security of the data files, including but not limited to site and
office access controls, secured file cabinets, and locked offices;
f.
The technical safeguards performed to protect
data stored on local workstations and onsite and external servers;
g.
The method of encryption used as the data sets are moved between
computers; and
h.
The technical safeguards performed to prevent the creation of additional
copies of the data;
(3) The qualifications of the investigator and
research staff demonstrate their ability to undertake the study or accomplish
the intended study as documented by:
a.
Training and previous research, including prior publications in the
proposed or related area; and
b. An
affiliation with a university, private research organization, medical center,
state agency, or other institution that will provide sufficient research
resources;
(4) The applicant has demonstrated that the data
sets are required in order to undertake the study or
accomplish the intended use;
(5) The applicant has never been found to have
violated the terms of a prior data use agreement;
(6) The claims data release advisory committee
has been given 45 days after receipt of the application to comment on the
merits of the application to the department in accordance with He-W 950.06(d)
below; and
(7) No other state or federal law, or federal
regulation prohibits release of the requested information.
(d)
If the department declines to release the limited use data sets, within
60 days of receipt of the application, the department shall provide a written
statement identifying the specific criteria that are the basis for denial of
the application.
(e)
Studies taking longer than 2 years shall require annual renewal of the
request.
(f) Except as provided in (i) below, the researcher shall provide the department with
a copy of any proposed release at least 30 days prior to publication or release
of any report or publication that contains information derived from the data
set so that the department has the opportunity to review the release and verify
that the agreed upon conditions have been applied.
(g)
If the department determines, based on the review required in (f) above,
that a report or publication containing information that might lead to direct
or indirect identification of patients, employers, or other group purchasers,
or is not within the scope of the agreed upon conditions, the department shall
provide a written statement to the researcher stating specifically the
problematic sections in the publication.
(h)
When the department issues a statement in accordance with (g) above, the
researcher shall modify the report or publication prior to its release by fully
addressing the problematic sections.
(i) When the department determines that multiple
reports will be of a similar nature, the department shall waive the requirement
that any subsequent reports or publications be provided to the department prior
to release by the researcher.
(j)
Any draft reports or publications supplied to the department shall be
treated as confidential and shall not be released by the department.
(k)
The department shall:
(1) Maintain records of applications for, and
releases of, limited use data sets and make them available for public
inspection;
(2) Maintain a system for tracking the dates by
which data sets shall be returned or destroyed; and
(3) Maintain records of the review of
publications, if applicable.
Source. #8600, eff
4-6-06; ss by #10703, eff 10-23-14 (from He-W 950.06); ss by #14166, eff 1-7-25
He-W 950.06 Claims Data Release Advisory Committee.
(a) The department shall establish a claims data
release advisory committee to provide non-binding advice and opinion on the
merit of applications for limited use data sets.
(b) The purpose of the claims data release
advisory committee shall be to review applications for limited use data sets
when requested to do so in accordance with (d) below, and to advise the
commissioner on whether:
(1) The release is consistent with:
a.
The statutory purpose of the comprehensive health care information
system (CHIS), established in accordance with RSA 420-G:11-a; and
b.
The requirements of Health Insurance Portability and Accountability Act
of 1996 (HIPAA) and its implementing regulations, 45 CRF Part 160-164; and
(2) The intended use of the data will:
a.
Contribute to efforts to improve health care for
b. Be
for research that employs appropriate analytical methods.
(c) The claims data release advisory committee
shall be annually appointed by the commissioner and consist
of the following members:
(1) One member representing insurance carriers;
(2) One member representing health care
facilities;
(3) One member representing health care
practitioners;
(4) One member representing the general public;
(5) One member representing purchasers of health
insurance;
(6) One member representing health care
researchers; and
(7) Two members of the department.
(d) Upon request from the commissioner, the
claims data release advisory committee shall review an application and provide
the commissioner with any comment on the merits of the application and the
research protocol described therein within 45 days.
Source. #8600, eff
4-6-06; ss by #10703, eff 10-23-14; ss by #14166, eff 1-7-25
He-W 950.07 Exemption
from Rule.
(a) Release of the entire claims data set to the
NHID shall be made without restriction except that the NHID shall defer to the
department any release of data sets and shall not release data sets to other
parties, except as specified in the data collection rules, Ins 4000, and except for the public use data set in whole or part.
(b) The department
and the NHID shall release data to their agents for specific projects as
needed.
(c) The department
and the NHID shall ensure that contracts with their agents contain signed
agreements to maintain the confidentiality of the data, prevent unauthorized
re-release of the data sets, and prevent the agents from using the data for
their own benefit or advantage.
(d) Release of data to state or federal agencies or
other government oversight entities or their contractors for health oversight
purposes shall be provided consistent with HIPAA, New
Hampshire state law, and federal laws.
Source. #8600, eff
4-6-06; ss by #10703, eff 10-23-14 (from He-W 950.08); ss by #14166, eff 1-7-25
(formerly He-W 950.08)
He-W 950.08 General
Limitation.
(a) The CHIS,
established in accordance with RSA 420-G:11-a, shall not contain direct patient
identifiers.
(b) Neither the department nor any employee or agent shall
receive, obtain, or otherwise possess direct patient identifiers or supply them
to others.
Source. #8600, eff
4-6-06; ss by #10703, eff 10-23-14 (from He-W 950.09); ss by #14166, eff 1-7-25
(formerly He-W 950.09)
APPENDIX
|
RULE |
STATUTE |
|
He-W
950.01 |
RSA
420-G:11-a |
|
He-W
950.02 |
RSA
420-G:11-a |
|
He-W
950.03 |
RSA
420-G:11-a |
|
He-W
950.04 |
RSA
420-G:11-a |
|
He-W
950.05 |
RSA
420-G:11-a |
|
He-W
950.06 |
RSA
420-G:11-a |
|
He-W
950.07 |
RSA
420-G:11-a |
|
He-W
950.08 |
RSA
420-G:11-a |